tryptophan and Cognition Disorders

tryptophan has been researched along with Cognition Disorders in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.50)18.7374
1990's3 (7.50)18.2507
2000's20 (50.00)29.6817
2010's16 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, W; Epperson, CN; Gur, RC; Loughead, J; Ruparel, K; Sammel, MD; Satterthwaite, TD; Shanmugan, S1
Advani, R; Giil, LM; Midttun, Ø; Refsum, H; Smith, AD; Ueland, PM; Ulvik, A1
Kanchanatawan, B; Maes, M1
Barichello, T; Comim, CM; Dominguini, D; Elias, SG; Generoso, JS; Quevedo, J; Simões, LR; Tashiro, MH; Teixeira, AL; Vilela, MC1
Allison, DJ; Ditor, DS1
Fuchs, D; Gostner, JM; Strasser, B1
Anderson, TJ; Collins, C; Dalrymple-Alford, JC; Mace, JL; Porter, RJ1
Fülöp, F; Klivényi, P; Szalárdy, L; Toldi, J; Vécsei, L; Veres, G; Zádori, D1
Anderson, G; Carvalho, AF; Geffard, M; Ivanova, R; Kanchanatawan, B; Maes, M; Noto, C; Ruxrungtham, K; Sirivichayakul, S; Thika, S1
Craig, HD; Eklund, JD; Seidler, NW1
Benkelfat, C; Coderre, E; Dumas, J; Naylor, M; Newhouse, PA; Sites, CK; Wilkins, H; Young, SN1
Booij, L; Van der Does, AJ2
Fuchs, D; Greilberger, J; Greilberger, M; Leblhuber, F; Tafeit, E; Wintersteiger, R1
Aviv, RI; Black, SE; Gold, AB; Herrmann, N; Kiss, A; Lanctôt, KL; Swardfager, W; Tennen, G1
Band, GP; Booij, L; Hommel, B; van der Does, AJ; van Steenbergen, H1
Blazevic, S; Colic, L; Culig, L; Hranilovic, D1
Buerger, K; Guillemin, GJ; Hampel, H; Schwarz, MJ; Teipel, SJ1
Deary, IJ; Ebmeier, KP; Stewart, ME1
Klaassen, T; Riedel, WJ; Schmitt, JA1
Lunn, BS; O'Brien, JT; Porter, RJ1
Honig, A; Riedel, WJ; Schmitt, JA; Sobczak, S1
Harrison, BJ; Nathan, PJ1
Gallagher, P; Massey, AE; McAllister-Williams, RH; Young, AH1
Riedel, WJ1
Riedel, WJ; Schmitt, JA; Sobczak, S1
Gallagher, P; O'Brien, JT; Phipps, AJ; Porter, RJ; Scott, A; Stevenson, PS1
Blair, RJ; Buzas, B; Finger, EC; Goldman, D; Marsh, AA; Pine, DS; Richell, RA; Soliman, N; Vythilingham, M1
Burgunder, JM; Chen, Q; Jiang, XF; Shang, HF; Zhou, D1
Gilles, C; Luthringer, R1
Oxenkrug, GF1
Booij, L; Haffmans, PJ; Merens, W; van der Does, A1
Kaufman, LD; Krupp, LB; Masur, DM1
Bender, DA1
Cowen, PJ; Dolan, RJ; Friston, KJ; Morris, JS; Smith, KA1
Ballard, CG; Gray, JM; Lunn, BS; O'Brien, JT; Porter, RJ; Walker, LL1
Van der Does, AJ1
Aan Het Rot, M; Booij, I; Deutz, NE; Honig, A; Riedel, WJ; Sobczak, S1
Bleandonu, G; Boye, J1

Reviews

9 review(s) available for tryptophan and Cognition Disorders

ArticleYear
The common inflammatory etiology of depression and cognitive impairment: a therapeutic target.
    Journal of neuroinflammation, 2014, Sep-02, Volume: 11

    Topics: Animals; Cognition Disorders; Depression; Humans; Inflammation; Kynurenine; Signal Transduction; Tryptophan

2014
Mood, food, and cognition: role of tryptophan and serotonin.
    Current opinion in clinical nutrition and metabolic care, 2016, Volume: 19, Issue:1

    Topics: Affect; Antioxidants; Brain; Cognition; Cognition Disorders; Depression; Diet; Feeding Behavior; Humans; Serotonin; Tryptophan

2016
Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).
    Expert opinion on therapeutic patents, 2016, Volume: 26, Issue:7

    Topics: Animals; Central Nervous System Neoplasms; Cognition Disorders; Drug Design; Enzyme Inhibitors; Humans; Kynurenine; Neurodegenerative Diseases; Patents as Topic; Structure-Activity Relationship; Tryptophan

2016
Tryptophan, mood, and cognitive function.
    Brain, behavior, and immunity, 2002, Volume: 16, Issue:5

    Topics: Affect; Attention; Cognition; Cognition Disorders; Depressive Disorder; Humans; Memory; Memory Disorders; Mood Disorders; Serotonin; Tryptophan

2002
Tryptophan modulation and cognition.
    Advances in experimental medicine and biology, 2003, Volume: 527

    Topics: Cognition; Cognition Disorders; Depression; Humans; Models, Psychological; Serotonin; Tryptophan

2003
Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs.
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:3

    Topics: Apomorphine; Cognition Disorders; Dopamine Agonists; Excitatory Amino Acid Antagonists; GABA Modulators; Humans; Ketamine; Lorazepam; Memory Disorders; Models, Psychological; Muscarinic Antagonists; Panic Disorder; Psychotropic Drugs; Scopolamine; Tryptophan

2007
Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
    Annals of the New York Academy of Sciences, 2007, Volume: 1122

    Topics: Aging; Animals; Cognition Disorders; Cytokines; Depressive Disorder, Major; Hormones; Humans; Kynurenine; Models, Biological; Nitric Oxide Synthase Type II; Tryptophan

2007
Tryptophan and niacin nutrition--is there a problem?
    Advances in experimental medicine and biology, 1996, Volume: 398

    Topics: Adult; Animals; Cognition Disorders; Environmental Exposure; Humans; Hydrolases; Iron Deficiencies; Kynurenine 3-Monooxygenase; Lead Poisoning; Liver; Mixed Function Oxygenases; NAD; NADP; Neoplasms; Niacin; Nutritional Requirements; Oxidative Stress; Trace Elements; Tryptophan; Zinc

1996
The effects of tryptophan depletion on mood and psychiatric symptoms.
    Journal of affective disorders, 2001, Volume: 64, Issue:2-3

    Topics: Anorexia Nervosa; Bipolar Disorder; Brain; Bulimia; Cognition Disorders; Depressive Disorder, Major; Humans; Mood Disorders; Obsessive-Compulsive Disorder; Recurrence; Serotonin; Severity of Illness Index; Substance-Related Disorders; Tryptophan

2001

Trials

10 trial(s) available for tryptophan and Cognition Disorders

ArticleYear
Impact of early life adversity and tryptophan depletion on functional connectivity in menopausal women: A double-blind, placebo-controlled crossover study.
    Psychoneuroendocrinology, 2017, Volume: 84

    Topics: Brain; Brain Mapping; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Life Change Events; Magnetic Resonance Imaging; Menopause; Middle Aged; Nerve Net; Placebo Effect; Serotonin; Tryptophan

2017
Acute tryptophan depletion and Lewy body dementias.
    International psychogeriatrics, 2016, Volume: 28, Issue:9

    Topics: Aged; Cognition Disorders; Cross-Over Studies; Deficiency Diseases; Dementia; Double-Blind Method; Female; Humans; Lewy Body Disease; Male; Memory, Short-Term; Neuropsychological Tests; New Zealand; Serotonin; Tryptophan

2016
Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.
    Menopause (New York, N.Y.), 2010, Volume: 17, Issue:4

    Topics: Affect; Aged; Aged, 80 and over; Anxiety; Cognition Disorders; Double-Blind Method; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Mental Recall; Middle Aged; Neuropsychological Tests; Phenylalanine; Postmenopause; Stress, Psychological; Tryptophan; Tyrosine

2010
Emotional processing as a predictor of symptom change: an acute tryptophan depletion study in depressed patients.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2011, Volume: 21, Issue:5

    Topics: Adolescent; Adult; Aged; Cognition Disorders; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Emotions; Humans; Mental Recall; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Reaction Time; Time Factors; Tryptophan; Young Adult

2011
Neuroticism as a predictor of mood change: the effects of tryptophan depletion.
    The British journal of psychiatry : the journal of mental science, 2002, Volume: 181

    Topics: Adult; Affect; Cognition Disorders; Depressive Disorder; Family; Female; Humans; Male; Neurotic Disorders; Psychometrics; Tryptophan

2002
Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly.
    Psychological medicine, 2003, Volume: 33, Issue:1

    Topics: Affect; Aged; Alzheimer Disease; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Serotonin; Task Performance and Analysis; Tryptophan

2003
Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjects.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2005, Volume: 13, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Beverages; Cognition Disorders; Convalescence; Cross-Over Studies; Depressive Disorder, Major; Disability Evaluation; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tryptophan

2005
Impaired recognition of fear facial expressions in 5-HTTLPR S-polymorphism carriers following tryptophan depletion.
    Psychopharmacology, 2006, Volume: 189, Issue:3

    Topics: Adult; Cognition Disorders; Double-Blind Method; Facial Expression; Fear; Female; Humans; Male; Polymorphism, Genetic; Recognition, Psychology; Serotonin Plasma Membrane Transport Proteins; Tryptophan

2006
Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer's disease.
    The American journal of psychiatry, 2000, Volume: 157, Issue:4

    Topics: Aged; Alzheimer Disease; Cognition Disorders; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Serotonin; Tryptophan

2000
Cognition following acute tryptophan depletion: difference between first-degree relatives of bipolar disorder patients and matched healthy control volunteers.
    Psychological medicine, 2002, Volume: 32, Issue:3

    Topics: Administration, Oral; Adult; Amino Acids; Bipolar Disorder; Cognition Disorders; Double-Blind Method; Female; Frontal Lobe; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Neuropsychological Tests; Risk; Serotonin; Tryptophan

2002

Other Studies

21 other study(ies) available for tryptophan and Cognition Disorders

ArticleYear
Kynurenine Pathway Metabolites in Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:2

    Topics: 3-Hydroxyanthranilic Acid; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Cognition Disorders; Cohort Studies; Female; Humans; Kynurenine; Male; Middle Aged; Neuropsychological Tests; Quinolinic Acid; Signal Transduction; Statistics, Nonparametric; Tryptophan; Xanthurenates

2017
The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
    CNS & neurological disorders drug targets, 2018, Volume: 17, Issue:6

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Cognition Disorders; Executive Function; Female; Humans; Immunoglobulin A; Immunoglobulin M; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Male; Middle Aged; Neuropsychological Tests; Picolinic Acids; Psychiatric Status Rating Scales; Quinolinic Acid; Schizophrenia; Schizophrenic Psychology; Tryptophan; Xanthurenates; Young Adult

2018
Inhibition of indoleamine 2,3-dioxygenase prevented cognitive impairment in adult Wistar rats subjected to pneumococcal meningitis.
    Translational research : the journal of laboratory and clinical medicine, 2013, Volume: 162, Issue:6

    Topics: Animals; Cognition Disorders; Cytokines; Enzyme Inhibitors; Hippocampus; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation Mediators; Male; Memory; Meningitis, Pneumococcal; Rats; Rats, Wistar; Translational Research, Biomedical; Tryptophan

2013
Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.
    Metabolic brain disease, 2017, Volume: 32, Issue:4

    Topics: Adolescent; Adult; Aged; Anxiety; Cognition Disorders; Depression; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Symptom Assessment; Tryptophan; Young Adult

2017
Trifluoroethanol increases albumin's susceptibility to chemical modification.
    Archives of biochemistry and biophysics, 2008, Dec-01, Volume: 480, Issue:1

    Topics: Acrolein; Anesthetics, Inhalation; Binding Sites; Biophysical Phenomena; Cognition Disorders; Fluorescence; Humans; In Vitro Techniques; Models, Biological; Postoperative Complications; Protein Conformation; Serum Albumin; Spectrometry, Fluorescence; Trifluoroethanol; Tryptophan

2008
Carbonyl proteins as a clinical marker in Alzheimer's disease and its relation to tryptophan degradation and immune activation.
    Clinical laboratory, 2010, Volume: 56, Issue:9-10

    Topics: Aged; Alzheimer Disease; Biomarkers; Cognition Disorders; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Neopterin; Oxidative Stress; Protein Carbonylation; Reference Values; Tryptophan; Vitamin B 12

2010
The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment.
    Journal of neuroinflammation, 2011, Feb-16, Volume: 8

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cognition Disorders; Cross-Sectional Studies; Enzyme Activation; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Male; Middle Aged; Psychiatric Status Rating Scales; ROC Curve; Stroke; Tryptophan

2011
Affective regulation of cognitive-control adjustments in remitted depressive patients after acute tryptophan depletion.
    Cognitive, affective & behavioral neuroscience, 2012, Volume: 12, Issue:2

    Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Analysis of Variance; Cognition Disorders; Conflict, Psychological; Depression; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Reaction Time; Serotonin; Social Adjustment; Tryptophan; Young Adult

2012
Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations.
    Behavioural brain research, 2012, Apr-21, Volume: 230, Issue:1

    Topics: 5-Hydroxytryptophan; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Male; Maze Learning; Monoamine Oxidase Inhibitors; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Serotonin; Sex Factors; Tranylcypromine; Tryptophan

2012
Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls.
    European archives of psychiatry and clinical neuroscience, 2013, Volume: 263, Issue:4

    Topics: Aged; Alzheimer Disease; Biomarkers; Blood-Brain Barrier; Brain Chemistry; Chromatography, High Pressure Liquid; Cognition Disorders; Female; Gas Chromatography-Mass Spectrometry; Humans; Kynurenic Acid; Kynurenine; Male; Neuropsychological Tests; Picolinic Acids; Quinolinic Acid; Spectrophotometry, Ultraviolet; Tryptophan

2013
Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:4

    Topics: Adult; Bipolar Disorder; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Infusions, Intravenous; Linear Models; Male; Memory Disorders; Psychomotor Performance; Statistics, Nonparametric; Tryptophan

2003
L-tryptophan challenge and cognitive deficits in bipolar disorder: evidence for hyperserotonergic and hypodopaminergic mechanisms.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:12

    Topics: Bipolar Disorder; Cognition Disorders; Dopamine; Humans; Serotonin; Tryptophan

2003
Effects of acute tryptophan depletion on executive function in healthy male volunteers.
    BMC psychiatry, 2003, Aug-04, Volume: 3

    Topics: Adolescent; Adult; Attention; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Frontal Lobe; Humans; Male; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Serotonin; Sex Factors; Trail Making Test; Tryptophan

2003
Cognitive changes after acute tryptophan depletion: what can they tell us?
    Psychological medicine, 2004, Volume: 34, Issue:1

    Topics: Alzheimer Disease; Cognition Disorders; Depressive Disorder, Major; Human Experimentation; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin; Tryptophan

2004
National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.
    Sleep, 2005, Volume: 28, Issue:9

    Topics: Adult; Antidepressive Agents; Benzodiazepines; Chronic Disease; Cognition Disorders; Cognitive Behavioral Therapy; Comorbidity; Cost of Illness; Depression; Humans; Incidence; Prevalence; Sleep Initiation and Maintenance Disorders; Tryptophan

2005
Novel mutation in the ceruloplasmin gene causing a cognitive and movement disorder with diabetes mellitus.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:12

    Topics: Ceruloplasmin; Cognition Disorders; Diabetes Complications; DNA Mutational Analysis; Exons; Female; Homozygote; Humans; Magnetic Resonance Imaging; Middle Aged; Movement Disorders; Mutation; Serine; Tryptophan

2006
Cognitive and serotonergic vulnerability to depression: convergent findings.
    Journal of abnormal psychology, 2007, Volume: 116, Issue:1

    Topics: Adult; Cognition Disorders; Cross-Over Studies; Depression; Double-Blind Method; Female; Humans; Male; Personality Disorders; Serotonin; Tryptophan

2007
The effects of experimentally lowered serotonin function on emotional information processing and memory in remitted depressed patients.
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:6

    Topics: Adolescent; Adult; Aged; Attention; Cognition Disorders; Depressive Disorder; Emotions; Face; Female; Humans; Learning; Male; Memory; Middle Aged; Pattern Recognition, Visual; Selective Serotonin Reuptake Inhibitors; Self Concept; Serotonin; Speech; Tryptophan; Young Adult

2008
Neurocognitive dysfunction in the eosinophilia-myalgia syndrome.
    Neurology, 1993, Volume: 43, Issue:5

    Topics: Attention; Cognition Disorders; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Memory; Middle Aged; Motor Activity; Psychological Tests; Tryptophan

1993
Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion.
    The British journal of psychiatry : the journal of mental science, 1999, Volume: 174

    Topics: Adult; Blood Flow Velocity; Brain Diseases; Cerebrovascular Circulation; Cognition Disorders; Depressive Disorder; Humans; Male; Middle Aged; Psychological Tests; Recurrence; Serotonin; Tomography, Emission-Computed; Tryptophan

1999
[Neuropsychiatric incidences in antitubercular treatment consisting of isoniazid or isoniazid and ethionamide (8 cases)].
    Annales medico-psychologiques, 1969, Volume: 127, Issue:2

    Topics: Acidosis; Adult; Alcoholism; Ammonia; Avitaminosis; Carboxy-Lyases; Chromatography, Paper; Chromatography, Thin Layer; Cognition Disorders; Coma; Drug Synergism; Ethionamide; Female; Humans; Isoniazid; Male; Mental Disorders; Methods; Middle Aged; Niacinamide; Pyridoxine; Renin; Seizures; Transaminases; Tryptophan; Tuberculosis, Pulmonary; Vitamin B 6 Deficiency

1969